Treatment of pemphigus
- PMID: 2001906
- DOI: 10.1111/j.1365-4362.1991.tb04229.x
Treatment of pemphigus
Abstract
Ninety-eight cases of various types of pemphigus were treated between 1978-1987. Sixty-one cases were pemphigus vulgaris (PV), 22 cases were pemphigus foliaceus, generalized type (PFG) in which one case developed pemphigus vegetans, 11 cases were pemphigus foliaceus localized type (PFL), and four cases were pemphigus erythematosus (PE). Fifteen mild cases of PV and three mild PFG were treated with corticosteroid (prednisolone or prednisone) alone, and dapsone or cyclophosphamide (CP) were added as treatment failed in two cases of each. Dapsone alone was used effectively in three cases of mild PV. Eight cases of moderate and three cases of severe PV, as well as five cases of moderate PFG, failed to respond to corticosteroid alone but were cleared by the addition of CP. Thirty-two moderate cases of PV and PFG treated with a combination of corticosteroid 60 mg/day plus initial CP and 14 severe cases of PV and PFG treated with corticosteroid 120 mg/day plus initial CP, resulted in clearing skin lesions in 2 months. Azathioprine or chlorambucil were substituted in three cases who developed CP toxicity. Addition of gold sodiumthiomalate in six refractory cases when the above regimens failed, caused a complete remission in two and partial control in four. Higher dosage of prednisolone or prednisone more than 120 mg/day has never been used. Eleven cases of PFL and four cases of PE were treated with uneventfully good results. Intercellular antibody titers became negative within 4.67 months except in refractory cases, however, the treatment was continued for at least 3 years. Herpes simplex superimposed infection was more common than herpes zoster infection.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.Am J Clin Dermatol. 2007;8(2):85-92. doi: 10.2165/00128071-200708020-00004. Am J Clin Dermatol. 2007. PMID: 17428113
-
Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.Dermatology. 2011;223(2):182-8. doi: 10.1159/000332848. Epub 2011 Oct 21. Dermatology. 2011. PMID: 22025028
-
Childhood pemphigus.Int J Dermatol. 1999 Jan;38(1):29-35. doi: 10.1046/j.1365-4362.1999.00618.x. Int J Dermatol. 1999. PMID: 10065607
-
Pemphigus foliaceus with circinated plaques and neutrophil pustules.J Cutan Pathol. 2016 Nov;43(11):1062-1066. doi: 10.1111/cup.12793. Epub 2016 Sep 9. J Cutan Pathol. 2016. PMID: 27514363 Review.
-
[Cutaneous pemphigus vulgaris. A case report].Rev Med Chil. 2013 Apr;141(4):525-30. doi: 10.4067/S0034-98872013000400015. Rev Med Chil. 2013. PMID: 23900375 Review. Spanish.
Cited by
-
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.Arch Dermatol. 2008 Jan;144(1):25-32. doi: 10.1001/archderm.144.1.25. Arch Dermatol. 2008. PMID: 18209165 Free PMC article. Clinical Trial.
-
Pemphigus vulgaris and infections: a retrospective study on 155 patients.Autoimmune Dis. 2013;2013:834295. doi: 10.1155/2013/834295. Epub 2013 Jun 13. Autoimmune Dis. 2013. PMID: 23844280 Free PMC article.
-
Bilateral herpetic keratitis presenting with unilateral neurotrophic keratitis in pemphigus foliaceus: a case report.J Med Case Rep. 2011 Jul 27;5:328. doi: 10.1186/1752-1947-5-328. J Med Case Rep. 2011. PMID: 21794135 Free PMC article.
-
Pemphigus autoimmunity: hypotheses and realities.Autoimmunity. 2012 Feb;45(1):7-35. doi: 10.3109/08916934.2011.606444. Epub 2011 Sep 23. Autoimmunity. 2012. PMID: 21939410 Free PMC article. Review.
-
Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome.J Korean Med Sci. 2006 Jun;21(3):585-7. doi: 10.3346/jkms.2006.21.3.585. J Korean Med Sci. 2006. PMID: 16778412 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous